Completed NA INTERVENTIONAL 2-arm
NCT07416812
Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations (IMPACT)
The Identification of Men With a Genteic Predisposition to Prostate Cancer: Targeted Screening in Men at Higer Genetic Risk and Controls Study
Sponsor: Institute of Oncology Ljubljana
Conditions
Hereditary Prostate Cancer Prostate Cancer
Updated 1 time since 2026 Last updated: Feb 13, 2026 Started: Mar 29, 2021 Primary completion: Nov 30, 2021 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07416812, this NA trial focuses on Hereditary Prostate Cancer and Prostate Cancer and remains completed. Sponsored by Institute of Oncology Ljubljana, it has been updated 1 time since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Institute of Oncology Ljubljana
Data source: Institute of Oncology Ljubljana
For direct contact, visit the study record on ClinicalTrials.gov .